These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 571950)

  • 1. The direct converstion of dopamine 3-O-sulfate to norepinephrine by dopamine-beta-hydroxylase.
    Buu NT; Kuchel O
    Life Sci; 1979 Feb; 24(9):783-9. PubMed ID: 571950
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-4-O-sulfate: a possible precursor of free norepinephrine.
    Buu NT; Kuchel O
    Can J Biochem; 1979 Sep; 57(9):1159-62. PubMed ID: 509357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of dopamine-beta-hydroxylase in the regulation of norepinephrine biosynthesis in rat brain.
    Wise CD; Belluzzi JD; Stein L
    Pharmacol Biochem Behav; 1977 Dec; 7(6):549-53. PubMed ID: 201940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 5. Isomer specific kinetics of dopamine beta-hydroxylase and arylsulfatase towards catecholamine sulfates.
    Strobel G; Werle E; Weicker H
    Biochem Int; 1990; 20(2):343-51. PubMed ID: 2317215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusaric acid-induced elevation of homovanillic acid in the CSF as an index of brain noradrenaline synthesis.
    Elghozi JL; Laude D; Chaouloff F
    Eur J Pharmacol; 1985 Nov; 117(3):363-7. PubMed ID: 4076351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The condensed matrix of mature chromaffin granules. The soluble form of dopamine beta-hydroxylase is catalytically inactive.
    Terland O; Flatmark T
    Adv Exp Med Biol; 2000; 482():55-67. PubMed ID: 11192601
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood pressure decreased by halobutylpicolinic acid, an inhibitor of dopamine beta-hydroxylase.
    Hidaka H; Takeya K
    Nature; 1972 Oct; 239(5371):334-5. PubMed ID: 12635227
    [No Abstract]   [Full Text] [Related]  

  • 9. Interference of inhibitors of dopamine-beta-hydroxylase with uptake of monoamines by chromaffin granular membranes.
    Schlichter D; Da Prada M; Pletscher A
    Eur J Pharmacol; 1975 Nov; 34(1):223-7. PubMed ID: 187432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
    Bonnay MM; Guerinot F; Bohuon CJ
    Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
    [No Abstract]   [Full Text] [Related]  

  • 12. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the interaction of Cibacron Blue and Procion Red with dopamine beta-monooxygenase.
    Skotland T
    Biochim Biophys Acta; 1981 Jun; 659(2):312-25. PubMed ID: 7260097
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism and kinetics of the inhibition of dopamine-beta-hydroxylase by 2-mercaptoethylguanidine.
    Diliberto EJ; DiStefano V; Smith JC
    Biochem Pharmacol; 1973 Dec; 22(23):2961-72. PubMed ID: 4761561
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 2-mercaptoethylguanidine and other compounds on norepinephrine synthesis by adrenal medullary granules.
    Diliberto EJ; DiStefano V
    Biochem Pharmacol; 1973 Dec; 22(23):2947-60. PubMed ID: 4761560
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of in vivo dopamine- -hydroxylase activity in rat brain.
    Stolk JM
    J Pharmacol Exp Ther; 1973 Aug; 186(2):230-40. PubMed ID: 4719778
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of dopamine beta-hydroxylase by some new thiourea derivatives.
    Oyama H; Izumi H; Ozawa H
    Biochem Pharmacol; 1976 Feb; 25(3):277-80. PubMed ID: 1267825
    [No Abstract]   [Full Text] [Related]  

  • 20. Catecholamine synthesis in the adrenal medulla of cattle and rats deficient in copper.
    Hesketh JE
    Biochem Soc Trans; 1981 Feb; 9(1):101-2. PubMed ID: 7215624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.